PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival

BACKGROUND: Hepatocellular carcinoma (HCC) patients undergo liver-directed therapy (LDT) to control tumor burden while awaiting liver transplantation with response impacting waitlist survival. In this study, we investigate the link between absolute lymphocyte count (ALC) and PD-1 expression with res...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez, Kelley G., Sandow, Tyler, Fort, Daniel, Hibino, Mina, Wright, Paige, Cohen, Ari J., Thevenot, Paul T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122885/
https://www.ncbi.nlm.nih.gov/pubmed/34689234
http://dx.doi.org/10.1007/s00262-021-03087-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122885/
https://www.ncbi.nlm.nih.gov/pubmed/34689234
http://dx.doi.org/10.1007/s00262-021-03087-z

Ejemplares similares